Gastroenterology Marketing Consultant & Advisor for GI Practices, Endoscopy & Digestive Health
The digestive tract is a long piece of real estate with an impressive ability to turn one symptom into fifteen Google searches. Gastroenterology has screening, chronic disease, procedures, hospital relationships, referral networks, pathology, anesthesia, worried patients and a scheduling system trying to keep all of it moving. I help GI organizations make that complexity easier to find, understand, trust and act on.
- GI growth is rarely one problem. Screening, general gastroenterology, IBD, hepatology, motility and advanced endoscopy can require very different strategies.
- A colonoscopy campaign can fail even with excellent demand if preparation, referrals, prior authorization, scheduling or procedure capacity become the bottleneck.
- Search and AI discovery should help people understand which doctor treats which problem, what happens next and how to access the right service without pretending to diagnose anyone online.
- Professional referrals remain essential for complex GI care. Referring clinicians need subspecialty clarity, access, communication and confidence in the handoff.
- Healthcare advertising and tracking deserve real privacy review. Google explicitly treats bowel health and invasive procedures as sensitive health interests for personalized advertising.
- I work on marketing, AI, search, communication, growth and business strategy. I am not a gastroenterologist and do not make clinical decisions.
Digestive health has a lot of doors. Here is how I think about them.
- Why GI is commercially different
- Five kinds of GI demand
- The gastroenterology specialty map
- What patients are actually trying to solve
- Screening and colonoscopy growth
- Endoscopy access and operations
- Referral relationships
- IBD and chronic care
- Hepatology and liver programs
- Advanced endoscopy and complex care
- Websites and useful medical content
- Organic, AI and voice discovery
- Paid media, privacy and tracking
- Reputation and patient confidence
- Economics, capacity and service mix
- Multi-location groups, ASCs and hospitals
- Measurement that means something
- A hypothetical GI growth problem
- How I approach the work
- Frequently asked questions
“Get more GI patients” is usually several business questions wearing one trench coat.
A gastroenterology practice can look simple from the parking lot. There are doctors, offices, procedures and people who would very much like their stomach to stop doing whatever it has decided to do. Inside the business, things get complicated quickly.
One physician may spend most of the week in general GI and screening. Another may focus on inflammatory bowel disease. Another may draw regional referrals for advanced endoscopy. A hepatologist may depend on a different referral network entirely. The group may own or partner with an ambulatory surgery center, share anesthesia resources, depend on pathology, manage infusion relationships, coordinate with colorectal surgery and operate across several locations with different physician schedules.
Marketing has to notice all of that. The commercially useful question is rarely “How do I get more traffic?” It is closer to: Which service should grow, for which patient or referral source, at which location, with how much capacity, and what has to happen after somebody raises a hand?
That is the specialist boundary for this page. My broader physician and surgeon marketing resource owns general medical-practice growth. This page goes deep on the business and discovery system around gastroenterology, hepatology, endoscopy and digestive health.
I am comfortable getting technical because the details are where strategy stops being generic. That does not make me a clinician. It makes me a marketer who would rather understand how the business works before spending money on it.
Five people can search for gastroenterology and be in five completely different journeys.
The person, the urgency, the evidence required and the next step all change. A serious growth strategy treats those differences as useful information instead of trying to funnel everybody into the same “Schedule now” button.
These journeys can overlap. A patient may enter through a screening test and end up needing therapeutic intervention. Someone with long-standing IBD may need a different subspecialist after moving to a new city. A patient with liver disease may be managed locally while also needing a tertiary relationship. Good marketing does not flatten those journeys. It makes the handoffs understandable.
Gastroenterology is broad enough that the website can become a routing system.
The list below is not a clinical taxonomy. It is a strategic map of the kinds of services that create different search, referral, content and access needs.
General gastroenterology
Broad digestive complaints, reflux, bowel changes, abdominal symptoms and common GI conditions can create direct patient search as well as primary-care referrals. Location, insurance, physician fit and access can matter enormously.
Screening & colonoscopy
Screening combines population health, patient education, payer rules, procedure capacity, bowel preparation, sedation, transportation, pathology and follow-up. Nobody puts colonoscopy prep on a vision board, so reducing unnecessary uncertainty is a real conversion function.
Inflammatory bowel disease
Crohn's disease and ulcerative colitis are long-term conditions with complex treatment and monitoring. A strong IBD program may need direct patient education, referral authority, physician reputation, multidisciplinary relationships and continuity-focused communication.
Hepatology
Liver programs can involve chronic disease, cirrhosis, viral hepatitis, metabolic liver disease, imaging, labs, transplant relationships and hospital care. The referral geography may be wider and the professional audience more important.
Motility & functional GI
Patients may arrive after a long diagnostic journey, multiple prior visits or confusing symptoms. Content has to be especially careful not to promise a simple answer to a complex clinical question.
Esophageal disease
Reflux, swallowing disorders, Barrett's esophagus, eosinophilic esophagitis and related services can sit at the intersection of common direct search and highly specialized evaluation.
Pancreatic & biliary care
These programs can depend heavily on advanced imaging, EUS, ERCP, hospital relationships, surgery, oncology and professional referrals. The language needs to work for clinicians and frightened families at the same time.
Advanced endoscopy
Referral criteria, physician expertise, procedural capabilities and the ability to get a complex patient into the right hands can matter more than broad local traffic.
Colorectal collaboration
GI often intersects with colorectal surgery, oncology, pathology and genetics. The practice should be clear about its own scope and the relationships surrounding more complex care.
Current clinical guidance moves quickly across these areas. The American College of Gastroenterology's guideline library currently includes 2025 and 2026 updates across Crohn's disease, ulcerative colitis, bowel preparation, upper endoscopy, EUS, ERCP and other GI topics. I use current specialty sources when clinical context affects public communication rather than treating a five-year-old blog post as timeless medical truth.
The patient may be searching for a symptom. The practice is organized around specialties. Somebody has to translate.
Patients do not always begin with a diagnosis. They begin with a sensation, a lab result, a family history, a referral, a positive screening test or a sentence from another doctor they only half remember after getting home.
That creates a translation problem. The organization knows its physicians by subspecialty. Search behavior is often messier:
- “Why do I keep having trouble swallowing?”
- “What happens after a positive FIT test?”
- “Do I need a gastroenterologist for fatty liver?”
- “What kind of doctor treats Crohn's disease?”
- “Can a colonoscopy find the cause of bleeding?”
- “Who does advanced endoscopy near me?”
- “How long does a colonoscopy take and do I need someone to drive me?”
The website should answer what can responsibly be answered and route the rest. It should not diagnose. It should not treat a symptom page like a substitute for clinical triage. It should help the person understand the practice, the kinds of problems its clinicians evaluate and the appropriate next step.
I like that challenge. Good medical communication respects intelligence on both sides. It can explain a complex service without turning the patient into a medical student or the physician into a generic headshot with three adjectives underneath.
Colorectal screening creates demand at population scale, but the communication still has to be precise.
As of August 2026, the current USPSTF final recommendation supports colorectal cancer screening for average-risk asymptomatic adults beginning at age 45 through age 75, with selective screening from 76 through 85 based on individual health, prior screening and preferences. The recommendation includes several screening strategies beyond colonoscopy. Read the USPSTF recommendation.
The CDC's colorectal cancer control program, updated in April 2026, likewise focuses on increasing screening among people ages 45 to 75. See the CDC program overview.
There is another trap: turning “screening” into shorthand for “sell more colonoscopies.” Current recommendations include stool-based tests and other direct visualization options. A responsible practice explains its services accurately and lets clinicians guide individual decisions. The marketing job is to make access, preparation and next steps understandable, not to turn preventive medicine into a retail promotion.
Medicare adds another layer of practical questions.
Medicare's current coverage page says Part B covers screening colonoscopies with no minimum age requirement, subject to coverage conditions and risk-based frequency. It also explains coverage of follow-up colonoscopy after certain positive non-invasive screening tests. Costs can change if tissue is removed. See Medicare's current screening colonoscopy coverage.
That does not mean a marketing page should promise an individual's coverage. It means insurance and financial communication should be good enough to explain what the practice can verify, what depends on the payer and what the patient should ask before the procedure.
The strategic question: Is the organization trying to increase screening among an eligible local population, convert inbound referrals faster, reduce leakage after a positive stool test, improve preparation completion, fill specific procedure blocks or grow a broader prevention program? Those are different problems.
Endoscopy growth can be lost between “yes, I should schedule” and the actual procedure.
This is where marketing meets scheduling, preparation, anesthesia, transportation, prior authorization, facility capacity and the human ability to follow instructions while living an ordinary life.
A campaign may create a hundred qualified inquiries. If twenty cannot get through, fifteen cannot get a timely appointment, ten fail to complete the required steps and another group cancels because instructions are unclear, the top of the funnel is not the whole story.
For GI, I pay attention to the entire transition from interest to completed care. That can include:
- phone answer and abandonment
- online request routing
- referral completeness
- insurance and authorization workflows
- open-access screening processes where clinically appropriate
- physician and facility scheduling
- bowel-preparation communication
- transportation requirements
- cancellation and no-show patterns
- pathology and follow-up communication
- recall and surveillance workflows
- patient questions before the procedure
The ACG and ASGE updated colonoscopy quality indicators in 2024, including priority indicators such as adenoma detection rate, bowel preparation adequacy, cecal intubation and recommended screening or surveillance intervals. Those are clinical quality measures, not marketing trophies. See the ACG-ASGE implementation document.
I mention them because they illustrate an important boundary: a serious GI growth strategy should understand that procedure volume sits inside a clinical quality system. Marketing should support appropriate access and patient understanding, while clinical teams own quality standards and clinical performance.
A gastroenterology referral is not just a name passed between offices. It is a transfer of confidence.
Primary care, internal medicine, surgery, oncology, emergency medicine and other specialties can all feed gastroenterology demand. The referring clinician usually wants several things at once: the right specialist, appropriate access, a clear handoff and confidence that communication will come back.
That is why referral development is partly relationship management and partly information design. A referring office should not need to call three numbers to learn which physician manages complex IBD, whether a hepatologist is accepting new referrals or where an advanced procedure is performed.
Useful referral resources can include physician subspecialty summaries, referral criteria, required records, urgent pathways, locations, direct professional contacts, program updates and educational content that is worth a clinician's time.
Digital visibility helps too. A PCP may know the group but not the newest physician. A surgeon may know one endoscopist but not realize the group now offers EUS at another location. A hospitalist may need to identify the appropriate outpatient follow-up service quickly. Clear public information strengthens the real-world network.
For larger service-line and system relationships, my hospital marketing work goes deeper into regional programs, health-system relationships and enterprise care delivery.
IBD marketing should feel more like a long-term care relationship than a campaign.
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases. NIDDK describes both as conditions that can involve periods of symptoms and remission, with diagnosis and treatment requiring medical evaluation and, in many cases, long-term management. NIDDK on Crohn's disease and NIDDK on ulcerative colitis.
Commercially, that changes the relationship. The practice may be competing for a long-term patient relationship, tertiary referrals, subspecialty reputation, physician authority and continuity. The patient may care about access during flares, medication management, testing, nutrition, insurance, infusion coordination, surgery relationships and whether the team appears capable of handling complexity.
The clinical evidence also evolves. ACG published updated adult Crohn's disease and ulcerative colitis guidelines in June 2025, and AGA continues to maintain current clinical guidance across IBD topics. ACG guidelines and AGA clinical guidance are better reference points for current treatment context than generic health content copied from one site to another.
What I would not do: write breathless “breakthrough treatment” copy around a therapy without source review, clinician approval and appropriate context. New options can be important without turning the website into a pharmaceutical infomercial.
Strong IBD content can answer practical questions, explain the program, show the physician's actual expertise, make referrals easier and reduce the emotional burden of figuring out where to start. It should also know when to stop talking and direct the patient back to the clinical team.
Liver programs often need a wider referral map and a more technical public story.
Hepatology can sit inside a GI group, a hospital program, an academic center or a broader transplant and specialty network. The service mix may include chronic liver disease, cirrhosis, viral hepatitis, metabolic liver disease, autoimmune disease, imaging, laboratory monitoring and relationships with transplant centers or tertiary programs.
Search behavior can begin with a lab result or imaging finding. Professional referrals can be more important than broad consumer acquisition. Geographic draw may be larger. The right content needs to explain the program to patients while also demonstrating enough substance that referring clinicians can recognize real expertise.
This is also where adjacent disciplines become visible. Laboratory testing, pathology, imaging and hospital care may all influence the journey. When the growth problem crosses into clinical diagnostics or scientific services, my laboratory marketing resource covers that commercial and technical side more directly.
I would rather write less and say something accurate than fill a liver page with generic claims about “advanced care.” If the program has specific expertise, technology, certifications, research involvement or multidisciplinary relationships, those should be explained precisely and supported. If it does not, marketing should not invent them.
Advanced endoscopy is a reminder that expertise can be the product people are trying to find.
Some GI services are driven by broad population demand. Others depend on a narrower network of referring physicians who need a specific capability. EUS, ERCP and other advanced procedures can sit in that second category, especially when they intersect with pancreatic, biliary, oncologic or complex therapeutic care.
The growth strategy therefore shifts. A local “gastroenterologist near me” campaign may be nearly irrelevant to the most valuable referral. More useful assets might include detailed physician expertise, procedure capabilities, referral pathways, hospital and facility information, professional education, regional visibility and a strong digital trail that lets a clinician verify the program quickly.
The American College of Gastroenterology's current guideline library includes updated competency and quality resources for EUS and ERCP. I use that as a reminder that advanced GI care is not simply a menu of procedures. Marketing has to stay in its lane while respecting the technical and quality frameworks clinicians work inside.
For answer engines and traditional search, this is also where specificity matters. “Advanced endoscopy” is an entity. The physician is another. The hospital or center is another. The procedure, disease area and referral region are others. Clear relationships among those things make the program easier for people to understand and easier for modern search systems to represent accurately.
The best gastroenterology websites do more than list conditions. They lower the cognitive load of getting care.
A patient may arrive anxious, embarrassed, uncomfortable or simply tired of feeling bad. Digestive health also involves topics people do not always discuss casually at dinner. The website should not make that harder.
I look for a practical sequence:
Understand
What does this physician or program treat? What kinds of tests or procedures are offered? What is the difference among the group's subspecialties?
Trust
Who is the clinician? What expertise is real and relevant? Is the information current, sourced and written like the organization respects the reader?
Act
Do I need a referral? Which location handles this service? How do I schedule? What should I bring? What happens next?
Condition pages, procedure pages, physician profiles, location pages and practical patient resources should support one another. That does not mean duplicating the same paragraph fifty times. It means creating a coherent body of information where each page has a useful job.
For a patient, a procedure page may explain general purpose, preparation, the care setting and questions to discuss with the clinical team. For a referring professional, the useful content may be indications, capabilities, physician expertise and referral instructions. For a complex program, the organization may also need research, publications, multidisciplinary relationships or technical resources.
I am especially wary of “medical content” that is technically polished and emotionally dead. A page can be clinically reviewed and still feel like it was written by an instruction manual. The objective is clarity with a pulse.
Modern GI discovery is part Google query, part conversation and part referral verification.
Traditional SEO still matters. Patients search symptoms, conditions, procedures, doctors, locations and insurance questions. Referring clinicians search specialists and programs. AI systems are increasingly asked to compare providers, explain terminology and identify what type of doctor handles a problem.
I approach those environments as one connected discovery system. The fundamentals are familiar: technically accessible pages, useful depth, clear physician and service information, credible sources, local relevance when geography matters, good internal relationships and enough authority that the organization deserves to be surfaced.
Then I add the conversational layer. Real people ask complete questions. Pages should be able to answer things such as:
- What does a gastroenterologist treat?
- When should someone see a GI specialist?
- What is the difference between a gastroenterologist and a hepatologist?
- What happens after a positive colorectal screening test?
- Which doctor treats Crohn's disease?
- What is advanced endoscopy?
- Does this GI practice perform procedures at an ambulatory surgery center?
A short answer can earn attention. The deeper page earns trust. My broader AI Search & Organic Growth resource explains how I connect SEO, GEO, AEO, entity clarity, technical discovery and authority across modern search environments.
No one controls whether ChatGPT, Gemini, Google or another system retrieves, summarizes or cites a particular page. I do not sell guaranteed AI citations. I improve the underlying information and authority that make accurate retrieval more plausible.
Healthcare ad technology has rules. Bowel health manages to make the policy language unusually specific.
Google currently classifies health as a sensitive interest category for personalized advertising and explicitly includes bowel or urinary health and invasive medical procedures in that category. Advertiser-curated audiences face restrictions when promoting sensitive health content. Google also updated its restricted-targeting guidance in June 2026 to clarify Demand Gen and Discovery serving implications. Google's current health policy.
That does not make paid search unusable for gastroenterology. It means account structure, audiences, measurement and landing pages need to match the current policy environment rather than relying on habits from ordinary consumer marketing.
Privacy has a separate legal and operational layer. HHS maintains guidance on online tracking technologies for HIPAA-regulated entities and business associates. That guidance also notes that a federal court vacated a portion involving certain unauthenticated public webpages, and HHS states that it is evaluating next steps. Read the current HHS tracking-technology guidance.
Paid media can still be valuable for high-intent searches, new locations, screening initiatives and selected services. The economics just have to be understood. A cheap click that produces the wrong patient, an unavailable service or a scheduling dead end is not cheap.
People read reviews for bedside manner. They also read them for whether anyone answered the phone.
Reputation in gastroenterology can be unusually operational. Reviews may mention the physician, but they can just as easily focus on scheduling, staff communication, wait time, billing confusion, procedure instructions or the experience at a separate endoscopy center.
That makes reputation useful beyond marketing. Patterns in public feedback can reveal friction that affects conversion and retention. If patients repeatedly praise a particular nurse, that says something. If they repeatedly describe being transferred four times before scheduling a procedure, that says something too.
I separate the reputation system into three layers:
| Layer | What I look for | Why it matters |
|---|---|---|
| Physician trust | Expertise, communication, credentials, clarity, reputation and relevant public authority. | Patients and referrers often choose the clinician, not merely the logo. |
| Practice experience | Scheduling, calls, staff interactions, portal communication, billing and follow-up. | The medical brand is experienced through operations. |
| Facility experience | Preparation, check-in, anesthesia, procedure day, discharge and instructions. | GI care may move between office and procedure site, but the patient experiences one journey. |
Review generation also needs privacy discipline. I want a process that invites appropriate feedback without exposing protected information or encouraging staff to reveal private details in a public response.
A lead is not the unit of value in gastroenterology. Capacity, appropriateness and downstream care matter.
GI groups can have very different economics depending on payer mix, physician compensation, procedure volume, facility ownership, anesthesia arrangements, pathology, infusion services, hospital contracts, physician capacity and service mix. I am not a reimbursement consultant or healthcare accountant. I still need enough business context to avoid optimizing the wrong thing.
A campaign that floods a fully booked general GI physician with low-acuity new-patient requests may worsen access. The same budget might be better used to fill a new location, grow screening blocks, support a new IBD specialist or expand a referral-driven advanced service.
I want to know:
- Which physicians have capacity?
- Which procedures have capacity?
- Which locations should grow?
- Which payer relationships matter?
- Which services are strategically important?
- Where do referrals leak?
- Where do cancellations occur?
- Which demand is inappropriate?
- What does growth do to staff workload?
- What happens if the campaign actually works?
The last question is the one that saves the most expensive headaches.
A two-physician practice and a 50-physician GI platform can use the same channels for completely different reasons.
Independent practices may care intensely about local search, physician reputation, referral relationships and a manageable acquisition system. Larger groups add governance, brand integration, location complexity, central scheduling, acquisitions, physician recruiting, market expansion and data normalization.
Ambulatory surgery centers add another operating layer. Hospital-affiliated groups add enterprise branding, facility relationships, system scheduling and service-line strategy. Private-equity-backed platforms may need to integrate acquired practices without erasing the physician reputation that made those practices valuable in the first place.
I look for four tensions that show up repeatedly:
Local vs. enterprise
Patients often know the doctor or local practice name. Leadership needs a scalable regional brand. Both can be true.
Centralized vs. specific
Central scheduling is efficient until the call center cannot tell which physician handles the requested service.
Volume vs. access
Growth targets can outrun physician, nurse, infusion or procedure capacity if marketing and operations do not share the same reality.
Standardization vs. expertise
Templates can create consistency, but specialty physicians still need enough room to explain why their expertise is different.
For organizations operating across search, paid media, websites, content and analytics as one system, my integrated digital marketing work covers the broader channel coordination. For executive leadership, prioritization and team direction, see Fractional CMO & Executive Strategy.
I want a GI dashboard that can survive a conversation with the practice administrator.
Rankings and traffic matter. So do calls, forms and ad conversions. They become more useful when connected to what the organization is trying to change.
| Signal | Useful question | What it cannot prove alone |
|---|---|---|
| Organic visibility | Are the right services, physicians and locations becoming easier to find? | Whether people can get scheduled or become appropriate patients. |
| Qualified inquiry | Are more people taking a relevant next step? | Whether the referral is complete, insurable or clinically appropriate. |
| Scheduled appointment | Is the practice converting demand into access? | Whether the visit happens or leads to the intended service line. |
| Referral volume | Which professional relationships and geographies are growing? | Whether the referrals fit strategic capacity. |
| Procedure utilization | Are desired procedure blocks filling appropriately? | Clinical quality, profitability or patient experience by itself. |
| Cancellation / no-show | Where is the journey breaking before care? | The reason without deeper operational analysis. |
| Reputation trend | What public experience patterns are strengthening or hurting trust? | The complete clinical quality picture. |
Clinical quality belongs to clinicians and the appropriate quality systems. Marketing performance belongs in a broader business picture. I care about the relationship between the two without pretending they are interchangeable.
Suppose a six-physician GI group says, “The practice needs more colonoscopies.” I would not open Google Ads yet.
This is an invented example to show the thinking, not a client story.
Imagine the group has two offices and one endoscopy center. Screening demand is decent. One younger physician has capacity. Two senior physicians are booked for weeks. The center has unused blocks on certain days. Referral volume from primary care has flattened. The website still says screening begins at 50. Calls spike on Monday mornings, and the group has no useful measurement of how many web inquiries become procedures.
The first job is to separate the problems.
Problem one: the public screening message is outdated. Fix it with clinician-approved content aligned to current guidance.
Problem two: physician capacity is uneven. Do not promote “the practice” generically if the resulting demand lands on doctors who are already full.
Problem three: referral relationships are stagnant. Map PCP sources, leakage, geography, access and whether referral offices understand the newer physician's role.
Problem four: procedure capacity exists on specific days. Marketing can support those blocks only if scheduling and patient eligibility can route appropriately.
Problem five: Monday call volume may be a conversion bottleneck. More advertising could make the phones worse before it makes the center busier.
Now the strategy has shape. Search content can update screening and physician visibility. Referral outreach can focus on capacity and access. Paid search can be tested selectively. Call tracking and scheduling outcomes can be measured. The website can direct patients toward the right physician and explain practical next steps.
Bring me the GI business problem before deciding it is a search problem.
I work directly with physician owners, executives, practice administrators, marketing leaders and teams that need senior judgment across growth, search, content, paid media, websites, analytics and strategy.
Sometimes the assignment is narrow: improve organic visibility for a new service, rebuild physician profiles, launch a location, understand why paid search is wasting money or make a complex program easier to explain. Sometimes the organization needs somebody to step back and connect the whole system.
I like gastroenterology because it rewards that kind of thinking. The specialty has real science, real operational constraints, very human anxiety, complex referrals and a delightful amount of terminology that can make a perfectly intelligent patient wonder if somebody changed languages halfway through the appointment.
I am comfortable reading the technical material, talking with physicians and operators, working through data and then translating the strategy into language normal humans will actually read. I do not need to pretend to be a gastroenterologist to respect the medicine or understand the business surrounding it.
A practical engagement can include
- practice and market analysis
- specialty and service-line strategy
- SEO and local search
- AI search, GEO and AEO
- physician and program positioning
- patient education content
- referring-physician resources
- PPC and paid acquisition
- WordPress and conversion strategy
- call and scheduling measurement
- reputation and review strategy
- multi-location growth
- ASC and service-line utilization strategy
- analytics and executive reporting
- fractional CMO or retained advisory
If the problem crosses the specialty boundary, I can also work across the larger Healthcare & Medical ecosystem, including hospitals, diagnostics, technology, workforce, patient access and executive growth strategy.
Gastroenterology marketing questions I would want answered before hiring anyone.
Some are marketing questions. Some are really access, privacy, operations or specialty questions in disguise. That distinction is useful.
What does a gastroenterology marketing consultant do?
I help gastroenterology practices, digestive health groups, endoscopy programs and related organizations connect growth strategy with patient discovery, referral development, search visibility, content, paid media, reputation, websites, access and measurement. The work should fit the actual service mix, physician capacity, procedure capacity and referral model rather than treating every GI practice like the same business.
How is gastroenterology marketing different from general physician marketing?
Gastroenterology combines office medicine, chronic disease management, screening, diagnostic testing, procedures, referral relationships and often ambulatory surgery center operations. A general physician strategy can explain the broad principles, but a GI strategy has to understand colonoscopy demand, endoscopy access, hepatology, IBD, motility, advanced procedures, pathology, anesthesia, preparation, no-shows and the handoffs that happen before and after a procedure.
Do you work with independent GI practices and large gastroenterology groups?
Yes. The strategic questions change with scale. A small independent group may need stronger local discovery and referral growth. A large regional platform may need physician and location structure, service-line prioritization, market expansion, call-center performance, brand integration and consistent measurement across many offices and endoscopy sites.
Can you help market colonoscopy and colorectal cancer screening?
Yes, from a marketing and patient-education perspective. Screening communication should accurately reflect current clinical guidance and should distinguish average-risk screening from diagnostic evaluation or higher-risk surveillance. I do not decide who should be screened or which test is appropriate for an individual patient. Those are clinical decisions.
What age should a gastroenterology website say colorectal screening starts?
The current USPSTF final recommendation says average-risk asymptomatic adults should be screened from age 45 through 75, with selective screening from 76 through 85 based on individual circumstances. A practice should make sure its public education matches its clinicians' current guidance, patient population and applicable payer rules rather than copying an old age-50 statement that has been sitting on a website for years.
Can SEO help a gastroenterology practice get more patients?
Yes, when search visibility is connected to the right services, locations, physicians and access pathways. GI search can include screening, symptoms, conditions, procedures, subspecialties and practical questions. More traffic is not automatically useful if the practice has no capacity for the service being promoted or if scheduling cannot route the patient correctly.
What should a gastroenterology practice optimize for AI search and voice search?
Clear answers to real patient and referral questions are a strong starting point. The practice should make physicians, subspecialties, services, locations, referral pathways and current educational information easy to understand. That helps people as well as search and answer systems. I focus on becoming a better source, not on promising control over what an AI product will say.
Can you help with gastroenterology PPC and Google Ads?
Yes. Paid search can be useful for selected high-intent services and locations, but healthcare advertising requires careful audience, tracking and landing-page decisions. Google treats health, including bowel health and invasive procedures, as a sensitive interest category for personalized advertising, so the account strategy has to respect current platform policy.
Can gastroenterology practices use remarketing audiences?
The answer depends on the platform, the data involved and the campaign. Google restricts advertiser-curated audiences for sensitive interest categories such as health. Separate from ad-platform rules, HIPAA-regulated organizations also need to evaluate how tracking technologies interact with protected health information. I flag those questions for appropriate privacy and legal review rather than assuming a marketing tool makes the decision for the practice.
Does a HIPAA badge or healthcare analytics vendor make a GI website compliant?
No. A vendor label does not automatically make an organization HIPAA compliant. HHS guidance makes clear that regulated entities remain responsible for how protected health information is handled. The correct analysis depends on the technology, the data, the page context, contracts and the organization's obligations.
Can you help improve gastroenterology physician referrals?
Yes. Referral growth can involve clearer subspecialty positioning, referring-physician resources, access information, service criteria, geographic outreach, professional education, relationship mapping and measurement of referral sources and leakage. A referral program works better when a physician can quickly understand who treats what and how fast the patient can be seen.
How should a GI group market inflammatory bowel disease care?
IBD growth usually needs more than a generic Crohn's or ulcerative colitis page. Patients may be managing a long-term relationship with the practice, medications, testing, nutrition concerns, hospitalizations and sometimes surgery. Referring clinicians may care about subspecialty expertise and access. Strong marketing explains the program clearly, keeps claims grounded in current evidence and makes continuity easier to understand.
Can you help hepatology and liver programs?
Yes. Hepatology can involve chronic liver disease, cirrhosis, viral hepatitis, metabolic liver disease, transplant relationships, imaging, laboratory monitoring and multidisciplinary care. The discovery and referral strategy may be more regional and professionally driven than routine general GI, so the website and outreach should reflect that difference.
Do you work with advanced endoscopy programs?
Yes. Advanced endoscopy can be a referral market built around specialized expertise, procedures, technology, hospital relationships and a much wider geographic draw than routine office GI. Marketing should make referral criteria, physician expertise, capabilities and access clear without overselling clinical outcomes.
Can marketing help an endoscopy center or ASC?
Yes, but the objective needs to be defined carefully. An ASC may need appropriate procedure volume, stronger physician alignment, better patient education, improved scheduling, reduced avoidable cancellations or clearer differentiation. Facility utilization, staffing, anesthesia, equipment and payer realities can constrain growth even when demand is strong.
What should a gastroenterology website say about bowel preparation?
It should make the practice's clinician-approved preparation instructions easy to find and easy to follow, with clear distinctions among procedures and preparation regimens when applicable. Preparation guidance can change and should be owned by the clinical team. From a communication standpoint, burying important instructions inside a difficult PDF is an avoidable source of friction.
How important are online reviews for gastroenterologists?
Reviews can influence trust and local decision-making, especially when patients are choosing among several nearby practices. I look beyond star averages. Patterns involving communication, scheduling, staff interactions, wait times and clarity can reveal operational issues that affect both reputation and conversion.
Can you help with a multi-location gastroenterology group?
Yes. Multi-location GI groups often need a clear relationship among physician profiles, subspecialties, office locations, endoscopy sites and service availability. Local visibility should reflect where care is actually available. Centralized scheduling, brand consistency and local physician reputation also need to work together rather than compete with one another.
How do you measure gastroenterology marketing performance?
I connect acquisition metrics to operational and business outcomes. Depending on the group, that can include qualified inquiries, scheduled visits, referral volume, screening conversions, procedure utilization, no-show and cancellation patterns, location performance, service-line mix, call outcomes and downstream case value. Clinical quality metrics remain clinical and should not be reduced to marketing KPIs.
Do you guarantee rankings, colonoscopy volume or practice revenue?
No. Search rankings, patient choices, referral behavior, payer conditions, staffing, physician capacity, facility capacity and clinical appropriateness are not fully controllable. I can improve the strategy, visibility, communication and measurement around growth, but guarantees would be unserious.
Are you a gastroenterologist or physician?
No. I am a marketing, growth, AI and business strategist. I can work deeply with medical subject matter and current authoritative sources, but I do not diagnose patients, recommend treatments or replace the judgment of licensed clinicians, compliance professionals or legal counsel.
Can you write medically technical gastroenterology content?
I can develop sophisticated patient, professional and strategic content in collaboration with the organization's subject-matter experts and authoritative sources. Clinical claims, treatment recommendations and practice-specific medical instructions should be reviewed and approved by appropriately qualified clinicians.
Do you work only with gastroenterology practices in Florida?
No. Paper Boat Media is based in DeLand, Florida, and I work nationally. Geography still matters because referral markets, competition, insurance networks, population growth and travel patterns affect GI demand, but the engagement is not limited to Florida.
Can you work as a consultant, fractional CMO or hands-on partner?
Yes. I can advise a physician owner or executive team, lead a focused growth project, coordinate existing staff and agencies, work as a fractional marketing leader or take direct responsibility for selected areas such as search, content, websites, analytics and paid acquisition. The role should match the problem rather than forcing the organization into a preset package.
What is the best first step if a gastroenterology group wants to grow?
Start with the business and access problem. Which service, physician, location or referral stream should grow? How much capacity exists? What is the patient or referrer trying to accomplish? Where does the current journey break? Once those answers are clear, it becomes much easier to decide whether the next investment belongs in search, content, paid media, referral development, scheduling, reputation, technology or something else.
Tell me which part of the gastroenterology business should be working better.
Maybe screening volume needs to grow. Maybe the advanced program deserves a wider referral footprint. Maybe a new physician has capacity, a new location is opening, the website is confusing, paid search is expensive or the call center is quietly eating the marketing budget. That is enough to start a useful conversation.
Professional boundary: Dr. Robert Urban provides marketing, business, AI, search, communication and growth strategy. He is not a physician or gastroenterologist and does not provide medical, legal, reimbursement or compliance advice. Clinical claims and patient-specific guidance belong with appropriately qualified professionals. Current regulatory and platform references on this page were reviewed against official sources in August 2026.